But you won't want to
Manufacturer Quality In the United States, dietary-supplement manufacturers are required to follow current good manufacturing practices under 21 CFR Part 111
The regulatory world isn't just a simple binary of "Approved" or "Illegal." There's a massive gray area where research chemicals reside
Reduces inflammation and oxidative stress: BPC157 appears to downregulate proinflammatory mediators and promote nitric oxide balance, which may help with chronic pain, arthritis, and fibromyalgia. Clinically, we use BPC157 as part of programs for: Tendon and ligament injuries Muscle strains and overuse injuries Gastrointestinal disorders like IBS, Crohns disease, ulcerative colitis, and reflux Leaky gut and systemic inflammation When combined in the Wolverine Stack, BPC157 tends to provide more localized repair at the site of injury and within the gut
MOTS -c is now on the F.D.A.s do-not-compound list, owing to the potential risk of immune reactions for certain routes of administration. Yet it, too, continues to circulate on the gray market
10.1074/jbc.M608820200 88